According to the Cancer Dependency Map (DepMap) portal, ∼8% of cancer cell lines are dependent on GCN2 based on CRISPR screening (https://www.proteinatlas.org/humanproteome/tissue/druggable). This evidence concerns the gene EIF2AK4 and cancer.